OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
Clinical trial NCT05587894 · RECRUITING
Trial details
- NCT number
- NCT05587894
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-27
- Primary completion
- 2026-06-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.